Dr. Reddy's launches generic Adcirca tabletsDr. Reddy's is introducing generic Adcirca, which had a market value of roughly $490 million. Mayne Pharma launches Lexette foamMayne is debuting a foam treatment for adult patients with plaque psoriasis. Lupin gets FDA nod for generic Prozac Lupin has received the FDA's nod for generic fluoxetine, which had a market value of roughly $42.5 million for the year ended December 2018. NACDS, NCPA praise groups supporting DIR fee reform NACDS and NCPA thanked 24 patient and consumer groups for taking a stance in support of DIR fee reform. PQA adds 1 to research team, promotes 4 medication quality experts The Pharmacy Quality Alliance has promoted four key staff members and added a director of measurement outcomes research. CDC: Flu vaccine prevented 8,000 deaths last flu season The flu vaccine prevented 7.1 million illnesses during the 2017-2018 flu season, according to a Centers for Disease Control and Prevention report. Sanofi, Regeneron lower prices for Praluent The lower-priced Praluent is expected to be available for pharmacies to order in early March. AAM to Congress: Reject 2019 Hatch-Waxman bill The Association for Accessible Medicines has told members of Congress that the Hatch-Waxman Integrity Act of 2019 would decrease patient access to generics and biosimilars. Teva unveils Alyq, its generic Adcirca Teva's generic of Eli Lilly's Adcirca is indicated to treat pulmonary arterial hypertension. J&J to include cost information in TV drug ads Janssen will include both the list price and potential patient out-of-pocket costs in future direct-to-consumer TV ads. First Previous 19 20 21 22 23 Next Last